23
Participants
Start Date
May 31, 2013
Primary Completion Date
March 31, 2016
Study Completion Date
May 31, 2016
Mexiletine
Sodium channel blocker
Placebo
Placebo
UCLA Neuromuscular Research Program, Los Angeles
UCSD Department of Neurosciences ALS Clinical Trials (ACT) Program, La Jolla
UC Irvine Health ALS & Neuromuscular Center, Orange
UC, Davis Medical Center ALS Clinic, Sacramento
UCD Telehealth Network - Lake Almanor Clinic, Chester
UCD Telehealth Network, Multiple Locations
University of California, Davis
OTHER
ALS Association
OTHER
Bjorn Oskarsson, MD
OTHER